OPKO RENAL LLC has a total of 25 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are EIGENBRODT ERICH, BRAINCELLS INC and PHYNOVA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Japan | 2 | |
#4 | Hong Kong | 1 | |
#5 | Hungary | 1 | |
#6 | Norway | 1 | |
#7 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Messner Eric J | 21 |
#2 | Bishop Charles W | 21 |
#3 | Crawford Keith H | 15 |
#4 | Petkovich P Martin | 8 |
#5 | White Jay A | 4 |
#6 | Tabash Samir P | 4 |
#7 | Agudoawu Sammy A | 4 |
#8 | Helvig Christian F | 3 |
#9 | Melnick Joel Z | 2 |
#10 | Messner Eric J J | 1 |
Publication | Filing date | Title |
---|---|---|
EP3335712A1 | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease | |
EP3047847A1 | Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |